The clinician looked at the screen, not at you. They asked what brought you in, and you had the feeling that the chart was being read for the first time while you spoke. You mentioned the fatigue, the weight that will not move, the sleep. You got a lab order, a word of reassurance, and a follow-up in six months. When the results came back marked normal, nobody called. You have been seeing this practice for years, and nobody there knows you.
It is tempting to conclude that you have a bad doctor. Usually you do not. Insurance-based primary care cannot know you, and this piece explains the mechanism, because once you see it the remedy is obvious and it is not a better doctor. It is a model paid differently.
- Insurance-based primary care is paid per visit, per code, so the practice survives on volume: a clinician typically manages 2,000 to 3,000 patients.
- The short visit and the unread lab result are the arithmetic of that model, not the character of the clinician.
- Direct primary care is paid as a flat monthly fee by the patient, which pays the practice to know you; panels of 300 to 600 are typical.
- GoodLife Health's membership is $299 a month for a named clinician, four cardiometabolic lab panels a year, messaging and video visits, no copay, no claim.
- The membership pairs with insurance for hospital, emergency and specialty care; it does not replace coverage.
- If you already have a clinician who knows you and has time, keep them.
The visit that was over before you finished
Every reader of this piece has had the visit. The symptoms you rehearsed in the car get two sentences. The clinician is typing. A question about hormones, thyroid, blood sugar or a medication you have read about gets a referral, a six-month follow-up or a gentle redirection to diet and exercise. The lab panel is the standard one, and it comes back normal, which ends the conversation without anyone explaining what normal means for a person with your history.
Then you pay. Under a traditional plan it is a copay; under a high-deductible plan it is the full negotiated price until the deductible is met, which the 2025 Kaiser Family Foundation survey puts at an average of $1,886 for single employer coverage. Either way the visit cost money and produced nothing you could act on.
What makes this hard to bear is that the clinician is usually competent and often kind. They went into medicine to know their patients. The model they work in will not let them, and the model is the subject of this piece.
The mechanism
Insurance-based primary care is paid by a plan, per visit, per billing code. The practice's income is the number of visits it can bill multiplied by what the plan pays for each, and plans do not pay much for primary care. So the practice needs volume, and the only way to get volume is to carry a large panel and keep each visit short. A clinician in this model typically manages 2,000 to 3,000 patients. The primary-care workforce projections published in the Annals of Family Medicine describe the pressure plainly: more patients per physician, year on year, with nothing in the payment structure pushing back.
Nothing in that model pays for the time between visits. Reading last year's panel against this year's is unpaid. Answering a message is unpaid. Thinking about a patient when the patient is not in the room is unpaid. The Journal of the American Board of Family Medicine's work on primary-care practices as learning organizations describes what continuity requires, and almost none of it is billable. A practice that did it anyway would go under. So the chart is read in the doorway, the result is filed as normal, and the follow-up is six months out because six months is the next slot.
Normal is a statistical range, not a verdict. A thyroid value inside the range can be the wrong value for a woman whose symptoms and family history say otherwise; a fasting glucose inside the range can be climbing year on year toward a diagnosis. Reading a result against a history takes time the per-visit model does not pay for, which is why the word normal so often closes a conversation that should have opened one.
The patient feels the model as a series of small absences. Nobody noticed that the fatigue you mentioned this year is the fatigue you mentioned last year. Nobody connected the weight gain to the thyroid value that drifted, because the two were filed in different visits by different people. Nobody called about the result, because calling is unpaid and the result was inside the range. Each absence is minor on its own, and together they are the experience of not being known, which is the thing the reader came to primary care to avoid.
This is why a better doctor does not fix it. A more attentive clinician in the same model carries the same panel, bills the same codes and runs out of the same minutes. The reader who has changed practices three times looking for someone who remembers them has been changing the person and keeping the model.
The reader who has changed practices three times looking for someone who remembers them has been changing the person and keeping the model.
The model paid to know you
Direct primary care turns the payment the other way round. The patient pays the practice a flat monthly fee, and the fee covers the care rather than each visit. Once the practice is paid that way, the economics invert: the clinician is paid to know the patient, because a known patient needs fewer visits, not more, and the practice does not lose money when a question is answered by message instead of in a billed appointment. The national survey of direct primary care practices describes the model across the country: smaller panels, typically 300 to 600 patients to a clinician, and a monthly fee in place of claims.
GoodLife Health applies that model to one clinical domain, cardiometabolic optimization: metabolic, hormonal and cardiovascular health treated as one system, labs first. The membership is $299 a month, month to month, with $598 charged at sign-up for the first two months. It includes clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in your own hands, asynchronous messaging with your care team, and video visits. There is no copay and no claim, and the fee is the same whatever medication is indicated and whatever the dose. What a direct primary care visit actually looks like walks through the first one.
Two things the model does not do, said plainly. It does not replace insurance: hospital, emergency, imaging and specialty care still need a plan, and most members keep a low-premium high-deductible one, paying the membership fee with HSA or FSA dollars, which is generally allowed. And it does not include medication: when a medication is indicated, the clinician prescribes it to the pharmacy you choose at that pharmacy's own price, GoodLife Health sets nothing, sees nothing and takes nothing on it, and only branded, FDA-approved medication is prescribed, never compounded GLP-1. Whether a plan covers a medication is between you, the plan and the pharmacy, and prior authorization is the pharmacy's process, so neither is promised. What a membership replaces, and what it does not is the companion piece for the reader weighing the whole arrangement.
What being known does clinically
Continuity sounds like a comfort. In cardiometabolic medicine it is a clinical instrument, and the reason is that almost everything that matters is a trend.
A single lab panel is a photograph. A clinician who sees only the photograph can say whether each value is inside its range, and that is what the word normal means on a result sent from a practice that does not know you. A clinician who has read your last four panels sees the film: the HbA1c that is inside the range but has climbed on every draw, the thyroid value that sits where it did last year while your symptoms have changed, the ApoB that explains a family history the standard lipid panel never flagged. Those are the findings that change what happens next, and none of them is visible in one visit to someone meeting you for the first time.
The same is true of treatment. A medication dose is a decision made over quarters, not in a visit: whether it is working, whether it is tolerated, whether the labs it is meant to move are moving, whether the dose should rise, hold or come down. In a model where each decision is a billed appointment with a different clinician reading the chart in the doorway, the decision defaults to the simplest one, which is usually to continue or to refer. In a model where the same clinician reads each panel against the last and answers a message in between, the decision is made on evidence, and it is made when the evidence appears rather than at the next available slot.
This is why the membership is built around four cardiometabolic lab panels a year and a named clinician rather than around visits. The visit is not the unit of care; the relationship is, and the panels are how the relationship sees.
What the first ninety days look like
For the reader deciding whether any of this is real, the first quarter is where it shows.
It begins with the eligibility check, the intake and the checkout, after which a clinician reviews your case. If you are accepted, the first panel is ordered and the results come to you and to the clinician at the same time. The first conversation is about those results in the context of your history: what is moving, what is not, what the plan is, and, if a medication is indicated, which one and why. Only branded, FDA-approved medication is prescribed, to the pharmacy you choose at its own price, and the clinician will tell you what they will not prescribe as readily as what they will.
Between that conversation and the next panel, the questions go by message and are answered by someone who has your numbers open. The follow-up that used to be six months away is a reply. At ninety days the panel is repeated, the clinician reads it against the first, and the plan is adjusted on evidence. By then you will know something you cannot know from this piece: whether being known by your clinician changes what happens to your health. Will I see the same clinician each time answers the question most readers ask next.
The honest close
If nobody at your practice knows you, the cause is a payment model, and the remedy is a payment model. A clinician paid per visit cannot afford to read your history; a clinician paid a flat fee by you is paid to. That is the entire difference, and it is why the same competent, kind people behave so differently inside the two models.
Not everyone is accepted. After the eligibility check, the intake and the checkout, a clinician reviews your case and decides. If they cannot accept you into care, the $598 is refunded in full; once you are accepted, the first two months are non-refundable. And the care is cardiometabolic, not urgent, pediatric or specialist care; the guide to what direct primary care does not cover is explicit about the edges.
Who this is not for
If you already have a clinician who knows your history, reads your labs against it and answers your messages, you have the thing this membership exists to provide. Keep them.
If you are healthy, take no medication and see a doctor once or twice a year, the per-visit model serves you adequately and costs you less. There is no relationship to buy because none is needed yet.
If you want a membership to pay for a hospital stay, it will not. It is primary care, paired with the plan that covers the rest.
If you want the cheapest possible prescription, a $99 a month app is a different product, and GoodLife Health does not prescribe compounded GLP-1 to compete with it.
Related Reading
- The Eight Minute Doctor Visit Problem
- What a Direct Primary Care Visit Actually Looks Like
- An Alternative to Traditional Insurance: What a $299 Membership Replaces
- Will I see the same clinician each time?
- What Direct Primary Care Does Not Cover
References
- Projecting US Primary Care Physician Workforce Needs: 2010-2025 (Annals of Family Medicine). 2012. doi.org/10.1370/afm.1474
- Primary Care Practice as a Learning Organization (J Am Board Fam Med). 2014. doi.org/10.3122/jabfm.2014.03.130239
- Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/
- 2025 Employer Health Benefits Survey — Kaiser Family Foundation. 2025. www.kff.org/health-costs/2025-employer-health-benefits-survey/